Table 1.
Characteristics of the chronic myeloid leukemia patients.
| Age | M/F | Hb (g/dl) | WBC (109/L) | Cytogenetics | BCR::ABL1 | SOKAL risk | |
|---|---|---|---|---|---|---|---|
| CML #1 | 40 | M | 14.8 | 42.35 | 46,XY,t(2;9:22)(p15;q11) | b3a2 | Low |
| CML #2 | 47 | F | 12.2 | 16.21 | 46,XX,t(9;22)(q34;q11) | b3a2 | Low |
| CML #3 | 66 | M | 15.8 | 33.07 | 46,XX,t(9;22)(q34;q11) | b2a2 | Low |
| CML #4 | 75 | M | 12.7 | 23.13 | 46,XX,t(9;22)(q34;q11) | b2a2 | Intermediate |
| CML #5 | 65 | M | 10.2 | 28.36 | 46,XX,t(9;22)(q34;q11) | b2a2 | Low |
| CML #6 | 73 | F | 11.4 | 19.88 | 46,XX,t(9;22)(q34;q11) | b3a2 | Intermediate |
| CML #7 | 51 | F | 12.5 | 32.61 | 46,XX,t(9;22)(q34;q11) | b3a2 | Intermediate |
| CML #8 | 72 | M | 14.8 | 27.87 | 46,XX,t(9;22)(q34;q11) | b3a2 | Low |
| CML #9 | 82 | F | 13.3 | 27.68 | 46,XX,t(9;22)(q34;q11) | b3a2 | Intermediate |
| CML #10 | 69 | F | 14.3 | 46.55 | 46,XX,t(9;22)(q34;q11) | b3a2 | Intermediate |
| CML #11 | 50 | F | 12.8 | 65.03 | 46,XX,t(9;22)(q34;q11) | b2a2 | Low |